Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil

Objective: Brain drug delivery for effective treatment of neurodegenerative disorders is limited due to the selective permeability of blood brain barrier (BBB). During the past few years, development of novel delivery system has attracted considerable attention of formulation scientists to overcome...

Full description

Saved in:
Bibliographic Details
Published in:Drug development and industrial pharmacy 2020-01, Vol.46 (1), p.8-19
Main Authors: Singh, Anurag Kumar, Mishra, Sunil Kumar, Mishra, Gaurav, Maurya, Anand, Awasthi, Rajendra, Yadav, Mukesh Kumar, Atri, Neelam, Pandey, Pawan Kumar, Singh, Santosh Kumar
Format: Article
Language:English
Subjects:
Alzheimer's disease
blood brain barrier
brain delivery
laponite
nanocomposite
nanotechnology
neurodegenerative disorders
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: Brain drug delivery for effective treatment of neurodegenerative disorders is limited due to the selective permeability of blood brain barrier (BBB). During the past few years, development of novel delivery system has attracted considerable attention of formulation scientists to overcome the permeability limitation caused by BBB. Significance: Based on the outcomes of this study and taking into consideration of the unique characteristics of laponite, it can be further explored to deliver many other central nervous system acting drugs. Methods: In the present study, laponite (LAP) nanocomposites were exploited for the improved brain delivery of donepezil (DZ) following encapsulation approach due to their nano-size and positive charge at pH
ISSN:0363-9045
1520-5762
DOI:10.1080/03639045.2019.1698594